Three-Year Study: Fortesta Gel’s Safety and Efficacy in American Males with Autoimmune Disorders
Reading Time: 2 minutes Introduction Testosterone replacement therapy (TRT) has become increasingly popular among American males experiencing hypogonadism. Fortesta, a topical testosterone gel, is one such treatment that has gained attention for its ease of use and efficacy. However, its safety profile in patients with autoimmune disorders remains a topic of significant interest and concern. This article presents a comprehensive three-year study evaluating the safety and immunological effects of Fortesta in American males with autoimmune conditions. Study Design and Methodology Our study included 200 American males aged between 30 and 65 years, all diagnosed with hypogonadism and various autoimmune disorders, such as rheumatoid arthritis,...


